(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) jumped by a staggering 27.25% in 21 sessions from $3.67 at 2023-04-17, to $4.67 at 11:55 EST on Tuesday, following the last session’s downward trend. NASDAQ is rising 0.17% to $12,386.53, following the last session’s upward trend.
TherapeuticsMD’s last close was $4.39, 62.45% below its 52-week high of $11.69.
About TherapeuticsMD
TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Earnings Per Share
As for profitability, TherapeuticsMD has a trailing twelve months EPS of $0.11.
PE Ratio
TherapeuticsMD has a trailing twelve months price to earnings ratio of 42.45. Meaning, the purchaser of the share is investing $42.45 for every dollar of annual earnings.
Volatility
TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was 4.63%, 1.06%, and 3.04%.
TherapeuticsMD’s highest amplitude of average volatility was 4.63% (last week), 3.11% (last month), and 3.04% (last quarter).
Sales Growth
TherapeuticsMD’s sales growth is negative 91.2% for the present quarter and negative 93.7% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TherapeuticsMD’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for TherapeuticsMD is 13091 which is 68.6% below its average volume of 40045.
More news about TherapeuticsMD (TXMD).
